Haemonetics Corp reports results for the quarter ended in September 30 - Earnings Summary

Haemonetics

07/11/2024 14:20

* Haemonetics Corp  HAE.N  reported quarterly adjusted
earnings of
$1.12​​ per share for the quarter ended September 30, higher
than the same quarter last year, when the company reported EPS
of 99 cents.  The mean expectation of ten analysts for the
quarter was for earnings of $1.07 per share. Wall Street
expected results to range from $1.03  to $1.10 per share.
    * Revenue rose 8.6% to $345.51 million from a year ago;
analysts
expected $342.65 million. 
    * Haemonetics Corp's reported EPS for the quarter was 66
cents​.
    * The company reported quarterly net income of $33.83
million.
    * Haemonetics Corp shares had fallen by 2.8% this
quarter and
lost 8.6% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 0.6%
in the last three months.​ 
    * In the last 30 days, one analyst negatively revised an
earnings
estimate

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 8 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the medical
equipment,
supplies & distribution peer group is also "buy"

Wall Street's median 12-month price target for Haemonetics Corp
is 113.50 
This summary was machine generated from LSEG data November 7 at
02:20 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2024      1.07           1.12           Beat
 Jun. 30 2024      1.01           1.02           Beat
 Mar. 31 2024      0.89           0.90           Beat
 Dec. 31 2023      0.94           1.04           Beat